SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001213900-22-004782
Filing Date
2022-02-01
Accepted
2022-02-01 16:00:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea154779-13dhanmi_spectrum.htm SC 13D 56960
  Complete submission text file 0001213900-22-004782.txt   58630
Mailing Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052
Business Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052 702-835-6300
SPECTRUM PHARMACEUTICALS INC (Subject) CIK: 0000831547 (see all company filings)

IRS No.: 930979187 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-49329 | Film No.: 22578809
SIC: 2834 Pharmaceutical Preparations

Mailing Address 14, WIRYESEONG-DAERO, SONGPA-GU SEOUL M5 05545
Business Address 14, WIRYESEONG-DAERO, SONGPA-GU SEOUL M5 05545 8224108796
Hanmi Pharmaceutical Co., Ltd. (Filed by) CIK: 0001904921 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M5 | Fiscal Year End: 1231
Type: SC 13D